HCPCS Level IIdrugActive
J0873
Inj daptomycin (xellia)
BETOS: O1E
Effective: 2025-01-01
Description
Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Daptomycin
Manufacturer
Xellia Pharmaceuticals USA, LLC.
HCPCS Dosage
1 MG
Billing Units
350.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.